✦ LIBER ✦

Glucocerebrosidase mutations among African-American patients with type 1 Gaucher disease

✍ Scribed by Park, J.K. ;Koprivica, V. ;Andrews, D.Q. ;Madike, V. ;Tayebi, N. ;Stone, D.L. ;Sidransky, E.

Publisher: John Wiley and Sons
Year: 2001
Tongue: English
Weight: 78 KB
Volume: 99
Category: Article
ISSN: 0148-7299
DOI: 10.1002/1096-8628(2001)9999:9999<::aid-ajmg1144>3.0.co;2-1

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Glucocerebrosidase gene mutations in pat

Glucocerebrosidase gene mutations in patients with type 2 Gaucher disease

✍ Deborah L. Stone; Nahid Tayebi; Eduard Orvisky; Barbara Stubblefield; Victor Mad 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 English ⚖ 216 KB 👁 1 views

## Communicated by Mark Paalman Gaucher disease, the most common lysosomal storage disorder, results from the inherited deficiency of the enzyme glucocerebrosidase. Three clinical types are recognized: type 1, nonneuronopathic; type 2, acute neuronopathic; and type 3, subacute neuronopathic. Type 2

Glucocerebrosidase mutations among chine

Glucocerebrosidase mutations among chinese neuronopathic and non-neuronopathic Gaucher disease patients

✍ Choy, Francis Y.M.; Wong, Karen; Shi, HuiPing 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 20 KB 👁 2 views

## To the Editor: Gaucher disease results from an inherited deficiency of the lysosomal enzyme glucocerebrosidase . Three clinical forms of Gaucher disease have been described: type 1, non-neuronopathic; type 2, acute neuronopathic; and type 3, subacute neuronopathic. Type I Gaucher disease is the

Novel mutations in African American pati

Novel mutations in African American patients with glycogen storage disease type II

✍ Nina Raben; Eunice Lee; Laura Lee; Rochelle Hirschhorn; Paul H. Plotz 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 74 KB

The infantile form of GSD II (an inherited deficiency of the lysosomal enzyme, acid α αglucosidase, Pompe disease) is a severe and invariably fatal disease characterized by a rapidly progressive generalized hypotonia, hepatomegaly, and cardiomegaly. We have recently demonstrated that African America

Type 1 Gaucher disease: Identification o

Type 1 Gaucher disease: Identification of N396T and prevalence of glucocerebrosidase mutations in the Portuguese

✍ Olga Amaral; Eugénia Pinto; Margarida Fortuna; Lucia Lacerda; M.C. Sá Miranda 📂 Article 📅 1996 🏛 John Wiley and Sons 🌐 English ⚖ 178 KB

Novel insertion mutation in a non-Jewish

Novel insertion mutation in a non-Jewish Caucasian type 1 Gaucher disease patient

✍ Choy, Francis Y. M.; Humphries, M. Lisa; Ferreira, Patrick 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 English ⚖ 132 KB

Gaucher disease is the most prevalent lysosomal storage disorder. It is autosomalrecessive, resulting in lysosomal glucocerebrosidase deficiency. Three clinical forms of Gaucher disease have been described: type 1 (nonneuronopathic), type 2 (acute neuronopathic), and type 3 (subacute neuronopathic).

A novel mutation (V191G) in a German-Bri

A novel mutation (V191G) in a German-British type 1 Gaucher disease patient

✍ Francis Y. M. Choy; M. Lisa Humphries; Yoav Ben-Yoseph 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 English ⚖ 46 KB

Gaucher disease results from mutations in the glucocerebrosidase gene (GBA/GeneBank J03059) located on human chromosome 1q21. Three clinical forms of Gaucher disease have been described: type 1, nonneuropathic; type 2, acute neuropathic; and type 3, subacute neuropathic. We have identified a novel m